| Mrs Mandy Jo Marshburn, CNM | |
|
801 Mccarthy Blvd, New Bern, NC 28562-5237 | |
| (252) 633-3942 | |
| (252) 633-3942 |
| Full Name | Mrs Mandy Jo Marshburn |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 14 Years |
| Location | 801 Mccarthy Blvd, New Bern, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215258793 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 177636 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastern Carolina Womens Center Pa | 0446341010 | 10 |
News Archive
Amgen today announced the publication of a biomarker analysis of Vectibix (panitumumab) in combination with FOLFOX, a type of oxaliplatin-based chemotherapy, for the first-line treatment of patients with metastatic colorectal cancer.
Researchers report on a previously unknown relationship between stem cell potency and the metabolic rate of their mitochondria -a cell's energy makers. Stem cells with more active mitochondria also have a greater capacity to differentiate and are more likely to form tumors.
A new study presented last week is coming one step closer to finding out whether or not an athlete's genetic makeup determines the severity of post-concussive brain function.
Clinical and Laboratory Standards Institute (CLSI) recently published "Validation of Automated Systems for Immunohematological Testing Before Implementation; Approved Guideline" (I/LA33-A). This document provides guidance to laboratory personnel for validating an automated system for immunohematological testing before implementation.
The U.S. Food and Drug Administration recently approved an application that permits B. Braun Medical Inc. (B. Braun) to deliver FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX® Drug Delivery System.
› Verified 3 days ago
| Entity Name | Eastern Carolina Womens Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962458265 PECOS PAC ID: 0446341010 Enrollment ID: O20070810000553 |
News Archive
Amgen today announced the publication of a biomarker analysis of Vectibix (panitumumab) in combination with FOLFOX, a type of oxaliplatin-based chemotherapy, for the first-line treatment of patients with metastatic colorectal cancer.
Researchers report on a previously unknown relationship between stem cell potency and the metabolic rate of their mitochondria -a cell's energy makers. Stem cells with more active mitochondria also have a greater capacity to differentiate and are more likely to form tumors.
A new study presented last week is coming one step closer to finding out whether or not an athlete's genetic makeup determines the severity of post-concussive brain function.
Clinical and Laboratory Standards Institute (CLSI) recently published "Validation of Automated Systems for Immunohematological Testing Before Implementation; Approved Guideline" (I/LA33-A). This document provides guidance to laboratory personnel for validating an automated system for immunohematological testing before implementation.
The U.S. Food and Drug Administration recently approved an application that permits B. Braun Medical Inc. (B. Braun) to deliver FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX® Drug Delivery System.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Mandy Jo Marshburn, CNM 801 Mccarthy Blvd, New Bern, NC 28562-5237 Ph: (252) 633-3942 | Mrs Mandy Jo Marshburn, CNM 801 Mccarthy Blvd, New Bern, NC 28562-5237 Ph: (252) 633-3942 |
News Archive
Amgen today announced the publication of a biomarker analysis of Vectibix (panitumumab) in combination with FOLFOX, a type of oxaliplatin-based chemotherapy, for the first-line treatment of patients with metastatic colorectal cancer.
Researchers report on a previously unknown relationship between stem cell potency and the metabolic rate of their mitochondria -a cell's energy makers. Stem cells with more active mitochondria also have a greater capacity to differentiate and are more likely to form tumors.
A new study presented last week is coming one step closer to finding out whether or not an athlete's genetic makeup determines the severity of post-concussive brain function.
Clinical and Laboratory Standards Institute (CLSI) recently published "Validation of Automated Systems for Immunohematological Testing Before Implementation; Approved Guideline" (I/LA33-A). This document provides guidance to laboratory personnel for validating an automated system for immunohematological testing before implementation.
The U.S. Food and Drug Administration recently approved an application that permits B. Braun Medical Inc. (B. Braun) to deliver FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX® Drug Delivery System.
› Verified 3 days ago
Jessica Ipock, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 801 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-3942 Fax: 252-633-3332 | |
Megan Terese Burnham, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 801 Mccarthy Blvd, New Bern, NC 28562 Phone: 252-633-3942 Fax: 252-633-3332 | |
Ms. Sandra G Blackburn, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2818 Neuse Blvd, New Bern, NC 28562 Phone: 252-636-4920 Fax: 252-636-6836 |